Principles of choise diagnostic methods and eradication Helicobacter pylori infection

dc.contributor.authorTiupka, Tetiana
dc.contributor.authorZalyubovska, Olga
dc.contributor.authorZlenko, Viсtor
dc.contributor.authorMinaieva, Alina
dc.date.accessioned2017-10-17T11:59:18Z
dc.date.available2017-10-17T11:59:18Z
dc.date.issued2017-03
dc.description.abstractModern eradication scheme is the result of years of discussion of the problem leading scientists in the world. The main requirements that apply currently to Helicobacter therapy are: high efficiency rate of treatment of at least 80%; well tolerated with frequency of side effects is less than 5%; short duration of treatment (2 weeks); the minimum probability of primary and secondary resistance; low cost drugs.The development of new antibiotics and their practical application is the only way to improve the effectiveness of therapy and solving the problem H. pylori resistance to drugs that will upgrade existing therapeutic treatment regimens of H. pylori infection.ru_RU
dc.identifier.citationPrinciples of choise diagnostic methods and eradication Helicobacter pylori infection / T. I. Tiupka, O. I. Zalyubovska, V. V. Zlenko, A. O. Minaieva // Medications for a person: modern problems of pharmacotherapy and prescription of medicines: modern pharmacotherapy of chronic obstructive pulmonary disease and bronchial asthma : мaterials of the International Scientific and Practical Conference, Kharkiv, March 30–31, 2017. – Kharkiv : NFaU, 2017. – P. 22–23.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/17711
dc.language.isoenru_RU
dc.subjectHelicobacter pyloriru_RU
dc.subjectoptimization of diagnosticru_RU
dc.titlePrinciples of choise diagnostic methods and eradication Helicobacter pylori infectionru_RU
dc.typeThesisru_RU

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
тези ліки людині англ..doc
Size:
30 KB
Format:
Microsoft Word

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
11.51 KB
Format:
Item-specific license agreed upon to submission
Description: